ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2023
Zinzino group total revenue increased 23% in Q4 and total revenue for the full year 2023 increased 23%, compared to the previous year.
The revenue in December for Zinzino's sales markets increased by 23 % and amounted to SEK 152.4 (123.8) million. Faun Pharma's external sales decreased and amounted to SEK 5.0 (5.1) million. Overall, the Group increased revenues by 22% to SEK 157.4 (128.9) million compared with the previous year.
Sales in Zinzino's sales markets increased by 24% in the fourth quarter of 2023 compared with the same period last year and amounted to SEK 511.2 (413.3) million. Total revenues in the Group increased by 23 % in the fourth quarter and amounted to SEK 529.8 (429.3) million.
Accumulated revenue for January – December 2023 increased by 23% to SEK 1768.3 (1443.1) million.
Revenues were distributed as follows:
| Regions, mSEK | 23-Dec | 22-Dec | Change | Q4 2023 | Q4 2022 | Change | YTD 2023 | YTD 2022 | Change |
| The Nordics | 26.7 | 34.3 | -22% | 82.9 | 90.9 | -9% | 300.0 | 326.6 | -8% |
| Central Europe | 43.3 | 27.8 | 56% | 134.9 | 94.3 | 43% | 437.9 | 290.8 | 51% |
| East Europe | 32,0 | 27,0 | 19% | 113.0 | 103.4 | 9% | 394.3 | 341.2 | 16% |
| South & West Europe | 25,0 | 14.9 | 68% | 86.8 | 50.6 | 72% | 267,0 | 164.6 | 62% |
| The Baltics | 8.4 | 7.2 | 17% | 31.5 | 25.3 | 24% | 98.3 | 77.9 | 26% |
| North America | 10.6 | 5.6 | 89% | 43.0 | 25.2 | 71% | 110.8 | 77.2 | 44% |
| Asia-Pacific | 5.5 | 5.8 | -5% | 15.8 | 19.8 | -20% | 56.8 | 77.5 | -27% |
| Africa | 0.9 | 1.2 | -25% | 3.2 | 3.8 | -15% | 13.2 | 10,0 | 32% |
| Zinzino | 152.4 | 123.8 | 23% | 511.2 | 413.3 | 24% | 1678.3 | 1365.8 | 23% |
| Faun Pharma | 5,0 | 5.1 | -2% | 18.7 | 16,0 | 17% | 90,0 | 77.3 | 16% |
| Zinzino Group | 157.4 | 128.9 | 22% | 529.8 | 429.3 | 23% | 1768.3 | 1443.1 | 23% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser:
Carnegie Investment Bank AB (publ)
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.